Healthcare organizations are facing increased scrutiny from federal regulators. This article breaks down the key differences between the DOJ's Corporate Enforcement Policy and the OIG's Self-Disclosure Protocol, helping providers better understand their compliance obligations and available pathways for self-disclosure.

MedPAC's latest ambulance cost data offers valuable insight, but it shouldn't be accepted at face value. Learn why EMS leaders should validate the data before using it to guide strategy, reimbursement discussions, and operational decisions.

The One Big Beautiful Bill Act is reshaping Medicaid eligibility, creating new compliance requirements for states and new operational challenges for providers. Alexandra Hembrough, Esq., explores what the latest federal guidance means, where providers should focus their attention, and how organizations can prepare for the changes ahead.

Too many organizations focus on claims that are easy to identify instead of those with the greatest reimbursement potential. Learn how a more strategic approach can uncover overlooked opportunities and improve revenue recovery.

The Federal IDR process is changing. Alexandra Hembrough, Esq., outlines the latest updates to the No Surprises Act Final Rule, explains what they mean for providers, and shares practical considerations for navigating the reimbursement process more efficiently.